Cost-Effectiveness Comparison of Genotype 1 Hepatitis C Virus (HCV) Treatments Using Telaprevir (TVR) in Patients with Mild Fibrosis Versus Patients with Bridging Fibrosis and Cirrhosis
Abstract
Authors
E.R. D’Angelo E. Gonzalez R. Sola